Drug Profile
Diphencyprone - Phio Pharmaceuticals
Alternative Names: Diphenylcyclopropenone; SamcyproneLatest Information Update: 21 Nov 2018
Price :
$50
*
At a glance
- Originator Hapten Pharmaceuticals
- Developer Hapten Pharmaceuticals; Phio Pharmaceuticals
- Class Antineoplastics; Antivirals; Cyclopropanes; Haptens; Skin disorder therapies; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Alopecia areata; Cancer metastases; Warts
Highest Development Phases
- Phase II Alopecia areata; Cancer metastases; Warts